Abstract
Introduction: Delayed enteral nutrition is associated with a higher risk for adverse outcomes in extremely preterm infants. Limited evidence exists on therapeutic options to support meconium evacuation and increase gastrointestinal motility. The aim of this study was to determine the effect of macrogol on feeding tolerance and microbiome establishment in preterm infants <27 weeks of gestation. Methods: We investigated the impact of early macrogol administration in two observational cohort studies: the multi-center German-Neonatal-Network (GNN) study comparing extremely preterm infants born in neonatal intensive care units (NICUs) using macrogol in the first week of life in >30% of their infants as compared to the remaining units, and the single-center Immunoregulation-of-the-Newborn (IRoN) study including gut microbiome assessment of infants born before and after implementation of macrogol use in this NICU. Results: In the GNN study cohort including 4,290 infants, advancement to full enteral feedings was significantly faster in macrogol-using NICUs compared to the remaining NICUs (median/IQR: 14/12 vs. 16/14 days, p = 0.001). Risk for short-term outcomes such as sepsis or abdominal complications was not elevated in units with regular use of macrogol. In the IRoN cohort (n = 68), macrogol treated infants had a shorter time to reach full enteral feeding (median/IQR: macrogol 12/6, control 16/6 days, p = 0.004). Higher Bifidobacterium longum abundance in the gut microbiome correlated with acceleration to full enteral nutrition. Conclusion: Our observational data suggests that early off-label use of macrogol may support feeding advancement in highly vulnerable babies. These data provide a basis for a randomized controlled trial.
Journal Section:
Research Article
References
1.
Härtel
C
, Haase
B
, Browning-Carmo
K
, Gebauer
C
, Kattner
E
, Kribs
A
, et al. Does the enteral feeding advancement affect short-term outcomes in very low birth weight infants
. J Pediatr Gastroenterol Nutr
. 2009
;48
(4
):464
–70
. 2.
Karagol
BS
, Zenciroglu
A
, Okumus
N
, Polin
RA
. Randomized controlled trial of slow vs rapid enteral feeding advancements on the clinical outcomes of preterm infants with birth weight 750-1250 g
. JPEN J Parenter Enteral Nutr
. 2013
;37
(2
):223
–8
. 3.
Deshmukh
M
, Balasubramanian
H
, Patole
S
. Meconium evacuation for facilitating feed tolerance in preterm neonates: a systematic review and meta-analysis
. Neonatology
. 2016
;110
(1
):55
–65
. 4.
Mihatsch
WA
, Franz
AR
, Lindner
W
, Pohlandt
F
. Meconium passage in extremely low birthweight infants and its relation to very early enteral nutrition
. Acta Paediatr
. 2001
;90
(4
):409
–11
. 5.
Zhu
L
, Liu
W
, Alkhouri
R
, Baker
RD
, Bard
JE
, Quigley
EM
, et al. Structural changes in the gut microbiome of constipated patients
. Physiol Genomics
. 2014
;46
(18
):679
–86
. 6.
Ibrahim
T
, Li Wei
C
, Bautista
D
, Sriram
B
, Xiangzhen Fay
L
, Rajadurai
VS
. Saline enemas versus glycerin suppositories to promote enteral feeding in premature infants: a pilot randomized controlled trial
. Neonatology
. 2017
;112
(4
):347
–53
. 7.
Haiden
N
, Norooz
F
, Klebermass-Schrehof
K
, Horak
AS
, Jilma
B
, Berger
A
, et al. The effect of an osmotic contrast agent on complete meconium evacuation in preterm infants
. Pediatrics
. 2012
;130
(6
):e1600
–6
. 8.
Mank
E
, Sáenz de Pipaón
M
, Lapillonne
A
, Carnielli
VP
, Senterre
T
, Shamir
R
, et al. Efficacy and safety of enteral recombinant human insulin in preterm infants: a randomized clinical trial
. JAMA Pediatr
. 2022
;176
(5
):452
–60
. 9.
Kamphorst
K
, Sietsma
Y
, Brouwer
AJ
, Rood
PJ
, van den Hoogen
A
. Enemas, suppositories and rectal stimulation are not effective in accelerating enteral feeding or meconium evacuation in low-birthweight infants: a systematic review
. Acta Paediatr
. 2016
;105
(11
):1280
–7
. 10.
Gross
M
, Hummler
H
, Haase
B
, Quante
M
, Wiechers
C
, Poets
CF
. Interventions for promoting meconium passage in very preterm infants-A survey of current practice at tertiary neonatal centers in Germany
. Children
. 2022
;9
(8
):1122
. 11.
Gordon
M
, MacDonald
JK
, Parker
CE
, Akobeng
AK
, Thomas
AG
. Osmotic and stimulant laxatives for the management of childhood constipation
. Cochrane Database Syst Rev
. 2016
;2016
(8
):CD009118
. 12.
Lange
M
, Figura
Y
, Böhne
C
, Beske
F
, Bohnhorst
B
, Heep
A
. Management of prolonged meconium evacuation in preterm infants: a survey-based analysis in German Neonatal Intensive Care Units
. Acta Paediatr
. 2022
;111
(11
):2082
–9
. 13.
Geffers
C
, Baerwolff
S
, Schwab
F
, Gastmeier
P
. Incidence of healthcare-associated infections in high-risk neonates: results from the German surveillance system for very-low-birthweight infants
. J Hosp Infect
. 2008
;68
(3
):214
–21
. 14.
Bossung
V
, Lupatsii
M
, Dashdorj
L
, Tassiello
O
, Jonassen
S
, Pagel
J
, et al. Timing of antimicrobial prophylaxis for cesarean section is critical for gut microbiome development in term born infants
. Gut microbes
. 2022
;14
(1
):2038855
. 15.
Schloss
PD
, Westcott
SL
, Ryabin
T
, Hall
JR
, Hartmann
M
, Hollister
EB
, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities
. Appl Environ Microbiol
. 2009
;75
(23
):7537
–41
. 16.
McDonald
D
, Price
MN
, Goodrich
J
, Nawrocki
EP
, DeSantis
TZ
, Probst
A
, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea
. ISME J
. 2012
;6
(3
):610
–8
. 17.
Afgan
E
, Baker
D
, Batut
B
, van den Beek
M
, Bouvier
D
, Cech
M
, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update
. Nucleic Acids Res
. 2018
;46
(W1
):W537
–44
. 18.
Kim
CY
, Lee
M
, Yang
S
, Kim
K
, Yong
D
, Kim
HR
, et al. Human reference gut microbiome catalog including newly assembled genomes from under-represented Asian metagenomes
. Genome Med
. 2021
;13
(1
):134
. 19.
Zimmermann
J
, Kaleta
C
, Waschina
S
. Gapseq: informed prediction of bacterial metabolic pathways and reconstruction of accurate metabolic models
. Genome Biol
. 2021
;22
(1
):81
. 20.
Caspi
R
, Billington
R
, Keseler
IM
, Kothari
A
, Krummenacker
M
, Midford
PE
, et al. The MetaCyc database of metabolic pathways and enzymes: a 2019 update
. Nucleic Acids Res
. 2020
;48
(D1
):D445
–53
. 21.
Zheng
L
, Gai
L
, Wu
Y
, Kong
C
, Sun
F
, Gao
J
, et al. Breast milk enema and meconium evacuation among preterm infants: a randomized clinical trial
. JAMA Netw Open
. 2024
;7
(4
):e247145
. 22.
Rao
C
, Coyte
KZ
, Bainter
W
, Geha
RS
, Martin
CR
, Rakoff-Nahoum
S
. Multi-kingdom ecological drivers of microbiota assembly in preterm infants
. Nature
. 2021
;591
(7851
):633
–8
. 23.
Liu
L
, Ao
D
, Cai
X
, Huang
P
, Cai
N
, Lin
S
, et al. Early gut microbiota in very low and extremely low birth weight preterm infants with feeding intolerance: a prospective case-control study
. J Microbiol
. 2022
;60
(10
):1021
–31
. 24.
Bogaert
D
, van Beveren
GJ
, de Koff
EM
, Lusarreta Parga
P
, Balcazar Lopez
CE
, Koppensteiner
L
, et al. Mother-to-infant microbiota transmission and infant microbiota development across multiple body sites
. Cell host & microbe
. 2023
;31
(3
):447
–60.e6
. 25.
Yang
S
, He
J
, Shi
J
, Xie
L
, Liu
Y
, Xiong
Y
, et al. Characteristics of intestinal microbiota in preterm infants and the effects of probiotic supplementation on the microbiota
. Front Microbiol
. 2024
;15
:1339422
. 26.
Batta
VK
, Rao
SC
, Patole
SK
. Bifidobacterium infantis as a probiotic in preterm infants: a systematic review and meta-analysis
. Pediatr Res
. 2023
;94
(6
):1887
–905
. 27.
Mills
S
, Yang
B
, Smith
GJ
, Stanton
C
, Ross
RP
. Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond
. Gut microbes
. 2023
;15
(1
):2186098
. 28.
Su
X
, Gao
Y
, Yang
R
. Gut microbiota-derived tryptophan metabolites maintain gut and systemic homeostasis
. Cells
. 2022
;11
(15
):2296
. © 2025 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.
